Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02695888
Other study ID # 15-012431
Secondary ID 823913
Status Completed
Phase N/A
First received
Last updated
Start date March 2016
Est. completion date December 29, 2016

Study information

Verified date March 2018
Source University of Pennsylvania
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This research study examines the feasibility of using an in-vehicle mobile technology monitoring system to measure teen secondary task engagement during on-road driving as the outcome measure for a web-based intervention to prevent risky driving in novice teen drivers.


Description:

This research study examines the feasibility of using an in-vehicle mobile technology monitoring system to measure teen secondary task engagement during on-road driving as the outcome measure for a web-based intervention to prevent risky driving in novice teen drivers. Approximately 20 teens who have been licensed for less than 90 days will be enrolled and evaluated at baseline, ~1 week and ~4 weeks. Participants will complete an intervention after the ~1 week assessment. This study will provide information on the feasibility of the web-based intervention to prevent risky driving and estimation of effect size of the intervention on cell phone use while driving.


Recruitment information / eligibility

Status Completed
Enrollment 28
Est. completion date December 29, 2016
Est. primary completion date December 29, 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 16 Years to 17 Years
Eligibility Inclusion Criteria:

1. Males or females age 16-17 years at time of enrollment (i.e. can turn 18 while enrolled in research and still be eligible).

2. Has their own iPhone 4S or newer or Android 4.3 or newer smartphone with data plan

3. PA driver's license for 90 days or less at time of teen assent

4. Personal email address and computer and internet access

5. Ability to read and write English

6. Primarily drives one vehicle with the ability to accommodate the DriveID device

7. Parental consent and teen assent

Exclusion Criteria:

1. Participation in a Center for Injury Research and Prevention at CHOP teen driving study within the past 6 months

2. Unable to follow study procedures

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Risky Driving Prevention
The web-based intervention to prevent risky driving targets knowledge, attitudes, perceived control and norms about driver inattention, with strategies to keep attention on the roadway.
Teen Healthy Living
The control group will receive a web-based intervention for general health promotion and is designed to enhance participants' knowledge and ability to reduce their risk of adverse health conditions including, obesity and heart disease.

Locations

Country Name City State
United States Children's Hospital of Philadelphia Philadelphia Pennsylvania
United States University of Pennsylvania Philadelphia Pennsylvania

Sponsors (2)

Lead Sponsor Collaborator
University of Pennsylvania Children's Hospital of Philadelphia

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Retention of participants Proportion of participants enrolled who complete Study Visit 1, Study Visit 2, Study Visit 3 and Study Visit 4. Baseline (Study Visit 1) through approximately 1- month (Study Visit 4)
Secondary In-vehicle cell phone use Difference between the intervention and control group on frequency of cell phone use while driving as monitored by an in-vehicle device Baseline (Study Visit 1) through approximately 1- month (Study Visit 4)
Secondary Self-reported driving behaviors Difference between the intervention and control group on on self-report measures of driving behaviors Baseline (Study Visit 1) through approximately 1- month (Study Visit 4)
See also
  Status Clinical Trial Phase
Recruiting NCT06320626 - Pharmacokinetic-guided Dosing of Emicizumab Phase 4
Completed NCT03497663 - VIA Family - Family Based Early Intervention Versus Treatment as Usual N/A
Recruiting NCT04559633 - Cognitive and Behavioral Therapy in School Refusal N/A
Recruiting NCT05706376 - An Evidence-based Family Support Program for Parents and Children in Palestine: A Theory-based Intervention N/A
Completed NCT04409106 - The Turkish Version of the Parental Smartphone Use Management Scale (PSUMS)
Not yet recruiting NCT04400526 - Development of a Community-based Network for Drug Abusers N/A
Enrolling by invitation NCT03312504 - Implementing a School Prevention Program to Reduce Injuries Through Neuromuscular Training N/A
Completed NCT04103632 - Screening and Diagnosing Exercise-induced Bronchoconstriction in Recreational Young Athletes (12-18 y) N/A
Completed NCT04448678 - Improving Health Insurance Experiences for Adolescent and Young Adult Cancer Patients N/A
Completed NCT01718080 - The Effects of Puberty and Weight on Sugar Metabolism in Children N/A
Recruiting NCT05423444 - Neural Connectivity During Therapy for Adolescent PTSD N/A
Completed NCT04443231 - Prospective Clinical Study of Retinal Microvascular Alteration After ICL Implantation
Not yet recruiting NCT03874078 - Turkish Version of Kids BESTest, Validity and Reliability for School-Aged Children
Recruiting NCT05265689 - Study to Improve Adolescent Bicycling Safety N/A
Enrolling by invitation NCT05572398 - Online Bullying Bystander Intervention for Middle Schools Phase II N/A
Recruiting NCT03176875 - Comparison of Partial and Exclusive Enteral Nutrition in the Treatment of Active Childhood-onset Crohn's Disease N/A
Completed NCT03842735 - Physical Activity in Children During Hematopoietic Stem Cells Transplantation (HSCT) N/A
Completed NCT00956527 - Martial Arts as Early Intervention for Teen Drug Abuse N/A
Active, not recruiting NCT04893447 - Suicide Prevention Among Recipients of Care N/A
Recruiting NCT05799053 - Peppermint Oil for the Treatment of Irritable Bowel Syndrome or Functional Abdominal Pain in Children: the MINT Study Phase 3